Mettler-Toledo International (NYSE:MTD) Price Target Lowered to $1,350.00 at Wells Fargo & Company

Mettler-Toledo International (NYSE:MTD) had its price target reduced by Wells Fargo & Company from $1,400.00 to $1,350.00 in a report issued on Monday,Benzinga reports. They currently have an equal weight rating on the medical instruments supplier’s stock.

A number of other research analysts have also weighed in on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Stifel Nicolaus lifted their price target on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a research report on Monday, August 5th. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Finally, Robert W. Baird cut their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus price target of $1,338.75.

Mettler-Toledo International Stock Performance

NYSE:MTD traded up $15.03 during trading hours on Monday, reaching $1,265.10. The stock had a trading volume of 7,308 shares, compared to its average volume of 133,577. Mettler-Toledo International has a 12-month low of $1,015.29 and a 12-month high of $1,546.93. The stock has a 50 day simple moving average of $1,394.23 and a 200 day simple moving average of $1,402.64. The stock has a market cap of $26.84 billion, a P/E ratio of 33.70, a price-to-earnings-growth ratio of 3.83 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The business had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a negative return on equity of 532.25% and a net margin of 21.15%. On average, equities analysts expect that Mettler-Toledo International will post 40.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In related news, insider Christian Magloth sold 1,000 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the transaction, the insider now directly owns 734 shares in the company, valued at approximately $1,044,459.98. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.94% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

A number of large investors have recently modified their holdings of MTD. Gateway Investment Advisers LLC bought a new position in Mettler-Toledo International during the second quarter valued at approximately $685,000. Swedbank AB bought a new position in shares of Mettler-Toledo International during the 1st quarter valued at $26,867,000. SG Americas Securities LLC raised its position in Mettler-Toledo International by 501.6% in the 1st quarter. SG Americas Securities LLC now owns 2,954 shares of the medical instruments supplier’s stock worth $3,933,000 after purchasing an additional 2,463 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in Mettler-Toledo International by 14.0% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock worth $1,860,000 after purchasing an additional 152 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC boosted its position in Mettler-Toledo International by 212.2% during the second quarter. Linden Thomas Advisory Services LLC now owns 1,308 shares of the medical instruments supplier’s stock valued at $1,828,000 after buying an additional 889 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.